Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Quiver Bioscience develops therapeutics that translate human neuronal biology into new treatments for brain disorders. The company combines patient-derived stem-cell disease models, advanced…

Quiver Bioscience develops therapeutics that translate human neuronal biology into new treatments for brain disorders. The company combines patient-derived stem-cell disease models, advanced…
Headquarters & focus: Cambridge, MA; develops CNS therapeutics using human neuron models, all‑optical electrophysiology, multi‑omics and AI
Modalities: Supports antisense oligonucleotides (ASO) and optogenetics; advances programs from discovery through preclinical/clinical
Notable programs: Nav1.7 and Nav1.8 programs for chronic pain; programs for seizure and neurodevelopmental disorders
Funding signals: Received NIH grant/HEAL Initiative funding (including NINDS) and other non‑dilutive grants
Founded 2013; ~40 employees; total disclosed funding ~$22.5M (grants)
Central nervous system (CNS) disorders including chronic pain, seizures, and neurodevelopmental disorders.
2013
Biotechnology
Multi‑year NIH HEAL Initiative award to advance Nav1.7 antisense therapy (QV‑2421) toward first‑in‑human trials; company has received non‑dilutive NIH funding and other grant support.
Recorded as a public funder on company profiles.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
4,700+
New This Week
| Company |
|---|